US EPA confirms risks of brominated flame retardants (Unknown)
In:
Chemical & Engineering News
;
100
, 24
;
17
;
2022
-
ISSN:
- Article (Journal) / Electronic Resource
-
Title:US EPA confirms risks of brominated flame retardants
-
Additional title:C&EN
-
Published in:Chemical & Engineering News ; 100, 24 ; 17
-
Publisher:
- New search for: American Chemical Society
-
Place of publication:Washington, DC
-
Publication date:2022-07-04
-
ISSN:
-
Coden:
-
DOI:
-
Type of media:Article (Journal)
-
Type of material:Electronic Resource
-
Language:Unknown
-
Keywords:
-
Source:
Table of contents – Volume 100, Issue 24
The tables of contents are generated automatically and are based on the data records of the individual contributions available in the index of the TIB portal. The display of the Tables of Contents may therefore be incomplete.
- 1
-
Table of Contents| 2022
- 4
-
Gender equity at risk| 2022
- 5
-
Reactions| 2022
- 6
-
Nickel catalyst enables versatile amine synthesis| 2022
- 7
-
Graphene oxide auto-cross-links| 2022
- 8
-
Graphene device monitors blood pressure| 2022
- 8
-
New clues about how Mars formed| 2022
- 9
-
Single catalyst molecules tracked in solution| 2022
- 10
-
A single sheet of bonded buckyballs| 2022
- 10
-
Videos show bonds in short-lived metal clusters| 2022
- 10
-
Fluorine-studded nanohoops| 2022
- 11
-
Albemarle to expand US lithium capacity| 2022
- 11
-
Tata and LG Chem advance carbon capture and utilization| 2022
- 13
-
Drug firms invest in malaria and neglected tropical diseases| 2022
- 13
-
Croda lands US funding for Pennsylvania lipids plant| 2022
- 14
-
Germany steps closer to rationing natural gas| 2022
- 14
-
PTT to build US recycling plant| 2022
- 14
-
Neste will expand renewable products| 2022
- 14
-
Stellantis invests in lithium producer| 2022
- 14
-
Avantium strikes PEF offtake deals| 2022
- 14
-
Electric Hydrogen gets electrolysis funds| 2022
- 14
-
Chemical makers eye carbon capture in China| 2022
- 15
-
Wacker to boost biotech R&D in Munich| 2022
- 15
-
Ipsen will acquire biotech firm Epizyme| 2022
- 15
-
Business Roundup| 2022
- 15
-
Astellas to pay Sutro $90 million for ADCs| 2022
- 15
-
Targeted protein drug firms advance| 2022
- 15
-
Vitamin E maker Kensing acquires Vitae| 2022
- 17
-
Hiring checklists help but don’t solve biases| 2022
- 17
-
US EPA confirms risks of brominated flame retardants| 2022
- 17
-
EPA to industry: Submit data up front| 2022
- 17
-
Melamine targeted for possible EU regulation| 2022
- 18
-
How to define PFAS| 2022
- 20
-
What’s that stuff? Health-monitoring cat litter| 2022
- 23
-
Career Ladder: Michael Mullowney| 2022
- 24
-
Looking for a summer listen?| 2022
- 27
-
The winding path out of the lab| 2022
- 28
-
From a shark to a possible Parkinson’s drug| 2022
- 30
-
Bringing an orphan drug to market| 2022
- 32
-
Setting up to deliver a therapy for ALS| 2022
- 34
-
Classifieds| 2022
- 34
-
Masthead| 2022
- 34
-
Units, keep away from unwritten rules| 2022
- 34
-
Ads| 2022
- 35
-
ACS launches 2 new applied materials journals| 2022
- 35
-
ACS announces 2 National Historic Chemical Landmark designations| 2022
- 35
-
Actions from the May ACS Board of Directors meeting| 2022
- 35
-
ACS conference in Qatar strengthens regional research community| 2022
- 36
-
Call for papers: Western Regional Meeting| 2022
- 36
-
Call for papers: Midwest Regional Meeting| 2022
- 36
-
Call for papers: Northeast Regional Meeting| 2022
- 36
-
ACS Publications commits hybrid journals to open access Plan S| 2022
- 37
-
ACS congratulates NSF Graduate Research Fellowship awardees| 2022
- 37
-
Call for papers: Southwest Regional Meeting| 2022
- 40
-
Ways to add a splash of color to your summer| 2022